AI Article Synopsis

  • Schizophrenia is a complex mental disorder linked to gene-environment interactions, with unclear underlying biology despite some emerging insights into brain anatomy.
  • Researchers studied Brd1 mice, which are genetically relevant to schizophrenia, to analyze brain structure using advanced imaging and cellular analysis methods.
  • Findings revealed abnormalities in key brain areas like the amygdala and striatum, including neuron loss and changes in specific neuron types, suggesting a connection to symptoms seen in human patients and emphasizing the Brd1 mouse model's potential for studying schizophrenia.

Article Abstract

Schizophrenia is a common and severe mental disorder arising from complex gene-environment interactions affecting brain development and functioning. While a consensus on the neuroanatomical correlates of schizophrenia is emerging, much of its fundamental pathobiology remains unknown. In this study, we explore brain morphometry in mice with genetic susceptibility and phenotypic relevance to schizophrenia (Brd1 mice) using postmortem 3D MR imaging coupled with histology, immunostaining and regional mRNA marker analysis. In agreement with recent large-scale schizophrenia neuroimaging studies, Brd1 mice displayed subcortical abnormalities, including volumetric reductions of amygdala and striatum. Interestingly, we demonstrate that structural alteration in striatum correlates with a general loss of striatal neurons, differentially impacting subpopulations of medium-sized spiny neurons and thus potentially striatal output. Akin to parvalbumin interneuron dysfunction in patients, a decline in parvalbumin expression was noted in the developing cortex of Brd1 mice, mainly driven by neuronal loss within or near cortical layer V, which is rich in corticostriatal projection neurons. Collectively, our study highlights the translational value of the Brd1 mouse as a pre-clinical tool for schizophrenia research and provides novel insight into its developmental, structural, and cellular pathology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220279PMC
http://dx.doi.org/10.1038/s41598-018-34729-5DOI Listing

Publication Analysis

Top Keywords

brd1 mice
16
loss striatal
8
medium-sized spiny
8
spiny neurons
8
brd1
5
mice
5
schizophrenia
5
brain volumetric
4
volumetric alterations
4
alterations accompanied
4

Similar Publications

NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer.

Sci Transl Med

November 2024

Department of Gastrointestinal Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.

Article Synopsis
  • 5-Fluorouracil (5-FU) resistance in gastric cancer is linked to low levels of the nitrilase family member 2 (NIT2), which plays a crucial role in overcoming this resistance through mechanisms unrelated to its metabolic functions.
  • The study revealed that NIT2 interacts with BRD1, inhibiting harmful gene expression related to cellular energy production, leading to enhanced sensitivity to 5-FU treatment.
  • Additionally, NIT2's presence is associated with better patient prognosis, and targeting oxidative phosphorylation with metformin can further improve the effectiveness of 5-FU in patients with low NIT2 levels.
View Article and Find Full Text PDF

mutation enhances and embryonic lethality in .

MicroPubl Biol

July 2023

Biochemistry, Molecular, Cellular and Developmental Biology Graduate Group, Department of Molecular and Cellular Biology, University of California, Davis.

In mice, mutation of results in embryonic lethality, which is partially suppressed by mutation. In contrast, mutation of the BRCA1 ortholog, or its binding partner, , lead to only mild embryonic lethality. We show that in , and embryonic lethality is enhanced when ortholog, , is also mutated.

View Article and Find Full Text PDF

Genetic studies have repeatedly shown that the Bromodomain containing 1 gene, BRD1, is involved in determining mental health, and the importance of the BRD1 protein for normal brain function has been studied in both cell models and constitutive haploinsufficient Brd1 mice. Homozygosity for inactivated Brd1 alleles is lethal during embryonic development in mice. In order to further characterize the molecular functions of BRD1 in the brain, we have developed a novel Brd1 knockout mouse model (Brd1) with bi-allelic conditional inactivation of Brd1 in the central nervous system.

View Article and Find Full Text PDF

Immune therapies have had limited efficacy in high-grade serous ovarian cancer (HGSC), as the cellular targets and mechanism(s) of action of these agents in HGSC are unknown. Here we performed immune functional and single-cell RNA sequencing transcriptional profiling on novel HGSC organoid/immune cell co-cultures treated with a unique bispecific anti-programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) antibody compared with monospecific anti-PD-1 or anti-PD-L1 controls. Comparing the functions of these agents across all immune cell types in real time identified key immune checkpoint blockade (ICB) targets that have eluded currently available monospecific therapies.

View Article and Find Full Text PDF

Reduced Brd1 expression leads to reversible depression-like behaviors and gene-expression changes in female mice.

Transl Psychiatry

July 2020

IPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark.

The schizophrenia-associated gene, BRD1, encodes an epigenetic regulator in which chromatin interactome is enriched with genes implicated in mental health. Alterations in histone modifications and epigenetic regulation contribute to brain transcriptomic changes in affective disorders and preclinical data supports a role for BRD1 in psychopathology. However, the implication of BRD1 on affective pathology remains poorly understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!